Vanderbilt Report Reveals Coeptis’s Funding Breakthrough
Coeptis Therapeutics is formalizing a dual-track operating model that pairs revenue generation with cell therapy development. In Q2 2025,...
eClinical Tech News
Positive Phase 2a Data for BPL-003 in Resistant Depression
Atai Life Sciences and Beckley Psytech reported positive proof-of-concept data for a two-dose induction regimen of BPL-003, an intranasal...
Genfit’s Latest H1 2025 Financial Results & Activities
Genfit reported first-half 2025 results alongside a decisive R&D reset: discontinuation of VS-01 in acute-on-chronic liver failure after a...
Synendos Phase 1 Shows Promise for Mental Health Treatment
Synendos Therapeutics reported positive topline results from a Phase 1 program of SYT-510, a first-in-class selective endocannabinoid reuptake inhibitor...
Biogen Provides Regulatory Update on High-Dose Nusinersen
Biogen received a Complete Response Letter from the FDA for its supplemental filing seeking a higher-dose regimen of nusinersen...
Genfit H1 2025 Financial Results & Company Activity Update
Genfit reported first-half 2025 results and a strategic refocus in liver disease. The company ended June with €107.5 million...
Benitec Biopharma Reports Full Year 2025 Financial Results
Benitec Biopharma reported full-year 2025 results and advanced its lead program, announcing an independent data safety monitoring board recommendation...
Promising Data: Cytisinicline for COPD Smoking Cessation
Achieve Life Sciences reported new peer-reviewed data showing its investigational agent, cytisinicline, significantly improved continuous abstinence rates versus placebo...
Cosmos Health Launches in $164B U.S. Nutraceuticals Market
Cosmos Health has launched its U.S. operations with the debut of Sky Premium Life Noor Collagen, a marine collagen...
NexoBrid Takes Spotlight at European Burns Association Congress
MediWound’s NexoBrid will take center stage at the European Burns Association Congress in Berlin this week, featured across 36...